Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 18/20 | 1.00 |
| ▸ | PDE3B | Q13370 | 1/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12671632 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL17974376 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL12634565 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL17325408 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL12634582 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL18737202 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL24467522 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL21470181 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL21498373 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL14980248 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 59059 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436366-B1 | — | — | None | — | — | US | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122094677-A | Organic compound | — | 2026-05-26 | — | — | CN | claimed |
| CN-122094676-A | Organic compound | — | 2026-05-26 | — | — | CN | claimed |
| CN-122067647-A | Prediction and depth verification integration method for traditional Chinese medicine compound action mechanism research | 国药集团德众（佛山）药业有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4741012-A2 | COMPOSITIONS AND METHODS FOR REDUCING AMYLOID BETA FORMATION AND COMPOSITION THEREFORE | Aribio Co., Ltd. (KR) | 2026-05-13 | — | — | EP | claimed |
| CN-117229211-B | NO donor type roflumilast derivative, preparation method, composition and application | 武汉科技大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260115312-A1 | Conjugates for neuroretinal drug delivery | MIRECA MEDICINES GMBH (DE) | 2026-04-30 | — | — | US | claimed |
| US-20260116886-A1 | DEUTERATED sGC STIMULATORS | TISENTO THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | claimed |
| US-12606618-B2 | Antagonist anti-NPR1 antibodies and methods of use thereof | REGENERON PHARMACEUTICALS, INC. (US) | 2026-04-21 | — | — | US | claimed |
| EP-0342015-A2 | Peptides, their use and pharmaceutical compositions containing them | IMMUNOBIOLOGY RESEARCH INSTITUTE, INC. (US) | 1989-11-15 | — | — | EP | claimed |
| EP-0341264-A1 | ATRIOPEPTINS, GUANYLATE CYCLASE ACTIVATORS, AND PHOSPHODIESTERASE INHIBITORS AS TREATMENT FOR GLAUCOMA, HYDROCEPHALUS AND CEREBRAL EDEMA (CRANIAL FLUID VOLUME DYSFUNCTION) | THE GENERAL HOSPITAL CORPORATION (US) | 1989-11-15 | — | — | EP | claimed |
| EP-0335386-A1 | KS-506 compounds and process for the production thereof | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1989-10-04 | — | — | EP | claimed |
| WO-1988005306-A1 | ATRIOPEPTINS, GUANYLATE CYCLASE ACTIVATORS, AND PHOSPHODIESTERASE INHIBITORS AS TREATMENT FOR GLAUCOMA, HYDROCEPHALUS AND CEREBRAL EDEMA (CRANIAL FLUID VOLUME DYSFUNCTION) | THE GENERAL HOSPITAL CORPORATION (US) | 1988-07-28 | — | — | WO | claimed |
| EP-0234854-A2 | Use of phosphodiesterase inhibitors and cyclic nucleotide analogues for the manufacture of a medicament for stimulating tear secretion | EYE RESEARCH INSTITUTE OF RETINA FOUNDATION (US) | 1987-09-02 | — | — | EP | claimed |
| US-4623666-A | CARDIOTONIC AGENTS, INCREASING CYCLIC GUANOSINE MONOPHOSPHATE | KENNEDY THOMAS P | 1986-11-18 | — | — | US | claimed |
| US-4554251-A | PSEUDOMYREMEX TRIPLARINUS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1985-11-19 | — | — | US | claimed |
| EP-0141182-A2 | Process and medium for culturing ant venom gland cells | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1985-05-15 | — | — | EP | claimed |
| US-4433061-A | ADDING A SOURCE OF DIVALENT CATION TO MINIMIZE INTERFERENCE OF CALCIUM CATIONS | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1984-02-21 | — | — | US | claimed |
| US-4115538-A | RADIOIMMUNOASSAY; ADENOSINE-3',5'-CYCLIC MONOPHOSPHATE, GUANOSINE-3',5'-CYCLIC MONOPHOSPHATE | YAMASU SHOYU KABUSHIKI KAISHA (JP) | 1978-09-19 | — | — | US | claimed |